ADC值联合血清SCCA、CA125对宫颈癌患者的分期及病理的研究进展
Research Progress of ADC Value Combined with Serum SCCA and CA125 in Staging and Pathology of Cervical Cancer Patients
摘要: 宫颈癌被认为是一种危及生命的妇科疾病，在女性中排名第二。宫颈癌在全球妇女中的发病率和死亡率均处于领先地位。最新的研究表明，宫颈癌的发病率可能与人乳头瘤病毒(human papilloma-virus, HPV)感染、性激素失调、子宫颈炎症、不良的性行为以及过度的性行为有着千丝万缕的关联。当前，鳞状细胞癌已成为宫颈癌的主要类型，其发病率高达70%~80%，在宫颈癌患者中占据重要地位。非鳞状细胞癌占组织学中的少数，但其预后一般较差。血清鳞状上皮细胞癌抗原(squamous cell carcinoma antigen, SCCA)和血清糖类抗原(carbohydrate antigen, CA125)是临床公认的宫颈鳞癌筛查的首选标志物，有助于宫颈癌的诊断和早期发现。同时，我们也不可否认影像学检查对于诊断宫颈癌的一些帮助，例如，磁共振扩散加权成像(DWI)对改善宫颈癌的诊断、治疗反应预测和预后提供了有利价值。
Abstract: Cervical cancer is considered as a life-threatening gynecological disease, ranking second among women. Cervical cancer leads the world in morbidity and mortality among women. Recent research suggests that the incidence of cervical cancer may be inextricably linked to human papillomavirus (HPV) infection, sex hormone imbalance, cervical inflammation, poor sexual behavior and excessive sexual activity. At present, squamous cell carcinoma has become the main type of cervical cancer, its incidence is up to 70%~80%, occupying an important position in cervical cancer patients. Non-squamous cell carcinoma accounts for a minority of histology, but its prognosis is generally poor. Serum squamous cell carcinoma antigen (SCCA) and serum carbohydrate antigen (CA125) are widely recognized as the preferred markers for cervical squamous cell carcinoma screening, which contribute to the diagnosis and early detection of cervical cancer. At the same time, there is no denying the help of imaging examinations in the diagnosis of cervical cancer. For example, diffu-sion-weighted magnetic resonance imaging (DWI) has provided beneficial value in improving the diagnosis, treatment response prediction and prognosis of cervical cancer.
文章引用：赵雅楠, 尹桂秀. ADC值联合血清SCCA、CA125对宫颈癌患者的分期及病理的研究进展[J]. 临床医学进展, 2023, 13(7): 10968-10973. https://doi.org/10.12677/ACM.2023.1371531

参考文献

[1] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA, 65, 87-108. [Google Scholar] [CrossRef] [PubMed]
[2] 范传朝, 陈爱敏. CT、MRI在宫颈癌诊断中的应用价值分析[J]. 医学影像学杂志, 2023, 33(1): 82-85.
[3] 覃飞, 车锦连, 薛元领, 等. MRI在宫颈癌诊断及分期中的应用[J]. 广西医科大学学报, 2013, 30(2): 258-260.
[4] Winer, R.L., Hughes, J.P., Feng, Q., Xi, L.F., Cherne, S., O’Reilly, S., et al. (2011) Early Natural History of Incident, Type-Specific Human Papillomavirus Infections in Newly Sexually Active Young Women. Cancer Epidemiol. Cancer Epidemiology, Biomarkers & Prevention, 20, 699-707. [Google Scholar] [CrossRef] 
[5] Wu, Y., Chen, Y., Li, L., Cao, Y., Liu, Z., Liu, B., et al. (2006) Polymorphic Amino Acids at Codons 9 and 37 of HLA-DQB1 Alleles May Confer Susceptibility to Cervical Cancer among Chinese Women. International Journal of Cancer, 118, 3006-3011. [Google Scholar] [CrossRef] [PubMed]
[6] de Graaff, J., Stolte, L.A. and Janssens, J. (1977) Marriage and Childbearing in Relation to Cervical Cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology, 7, 307-312. [Google Scholar] [CrossRef] [PubMed]
[7] Pozzan, C., Cardin, R., Piciocchi, M., Cazzagon, N., Maddalo, G., Vanin, V., Giacomin, A., Pontisso, P., Cillo, U. and Farinati, F. (2014) Diagnostic and Prognostic Role of SCCA-IgM Serum Levels in Hepatocellular Carcinoma (HCC). Journal of Gastroenterology and Hepatology, 29, 1637-1644. [Google Scholar] [CrossRef] [PubMed]
[8] Maddalo, G., Fassan, M., Cardin, R., Piciocchi, M., Marafatto, F., Rugge, M., Zaninotto, G., Pozzan, C., Castoro, C., Ruol, A., et al. (2018) Squamous Cellular Carcinoma Antigen Se-rum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer. Journal of Clinical Gastroenterology, 52, 401-406. [Google Scholar] [CrossRef] 
[9] Guo, S., Yang, B., Liu, H., Li, Y., Li, S., Ma, L., et al. (2017) Serum Expression Level of Squamous Cell Carcinoma Antigen, Highly Sensitive C-Reactive Protein and CA-125 as Potential Biomarkers for Recurrence of Cervical Cancer. Journal of Cancer Research and Therapeutics, 13, 689-692. [Google Scholar] [CrossRef] 
[10] Papathemelis, T., Knobloch, S., Gerken, M., et al. (2019) Impact of Nodal Status and Treatment Strategy on Overall Survival in Advanced Stage Cervical Cancer. Journal of Cancer Re-search and Clinical Oncology, 145, 1369-1376. [Google Scholar] [CrossRef] [PubMed]
[11] Zamani, N., Modares Gilani, M., Zamani, F. and Zamani, M.H. (2015) Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer. Journal of Family and Reproductive Health, 9, 177-183.
[12] 娄莉, 吴莎莎, 杜汉旺, 史晓林. MR扩散加权成像预测宫颈癌同步放化疗预后的作用[J]. 探讨影像研究与医学应用, 2021, 5(23): 49-50.
[13] Wilhelm, S.B. and Schlemmer, H.P. (2013) Whole-Body-MR-Diffusion Weighted Imaging in Oncology. Rofo, 184, 950-958. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, Y., Bai, R., Sun, H., Liu, H. and Wang, D. (2009) Diffusion-Weighted Magnetic Resonance Imaging of Uterine Cervical Cancer. Journal of Computer Assisted Tomography, 33, 858-862. [Google Scholar] [CrossRef] 
[15] Baliyan, V., Das, C.J., Sharma, R. and Gupta, A.K. (2016) Diffusion Weighted Imaging: Technique and Aooliications. World Journal of Radiology, 8, 785-798. [Google Scholar] [CrossRef] [PubMed]
[16] Kilickesmez, O., Bayramoglu, S., Inci, E., Cimilli, T. and Kayhan, A. (2009) Quantitative Diffusion-Weighted Magnetic Resonance Imaging of Normal and Diseased Uterine Zones. Acta Ra-diologica, 50, 340-347. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, Y.B., Hu, C.M., Chen, G.L., Hu, D. and Liao, J. (2011) Staging of Uterine Cervical Carcinoma: Whole-Body Diffusion-Weighted Magnetic Resonance Imaging. Abdominal Im-aging, 36, 619-626. [Google Scholar] [CrossRef] [PubMed]
[18] Naganawa, S., Sato, C., Kumada, H., Ishigaki, T., Miura, S. and Takizawa, O. (2005) Aapparent Diffusion Coefficient in Cervical Cancer of the Uterus: Comparison with the Normal Uterine Cervix. European Radiology, 15, 71-78. [Google Scholar] [CrossRef] [PubMed]
[19] Charles-Edwards, E.M., Messiou, C., Morgan, V.A., De Silva, S.S., McWhinney, N.A., Katesmark, M., et al. (2008) Diffusion-Weighted Imaging in Cervical Cancer with an Endo-vaginal Technique: Potential Value for Improving Tumor Detection in Stage ia and lbl Disease. Radiology, 249, 541-550. [Google Scholar] [CrossRef] [PubMed]
[20] Xue, H.D., Li. S., Sun, F., Sun, H.Y., Jin, Z.Y., Yang, J.X., et al. (2008) Clinical Application of Body Diffusion Weighted MR Imaging in the Diagnosis and Preoperative Nstaging of Cervical. Chinese Medical Sciences Journal, 23, 133-137. [Google Scholar] [CrossRef] 
[21] Balleyguier, C., Sala, E., Da, C.T., Bergman, A., Brkljacic, B., Danza, F., et al. (2011) Staging of Uterine Cervical Cancer with MRI: Guidelines of the European Society of Urogen-ital Radiology. European Radiology, 21, 1102-1110. [Google Scholar] [CrossRef] [PubMed]
[22] Hameeduddin, A. and Sahdev, A. (2015) Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI in Assessing Response and Recurrent Disease in Gynaecological Malig-nancies. Cancer Imaging, 15, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[23] Bell, D.J. and Pannu, H.K. (2011) Radiological Assessment of Gynecologic Malignancies. Obstetrics and Gynecology Clinics of North America, 38, 45-68. [Google Scholar] [CrossRef] [PubMed]
[24] Testa, A.C., Di, L.A., De Blasis, I., Moruzzi, M.C., Bonatti, M., Collarino, A., et al. (2014) Imaging Techniques for the Evaluation of Cervical Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 28, 741-768.
[25] Liu, Y., Zhang, Y., Cheng, R., et al. (2019) Radiomios Analysis of Ap-parent Diffusion Coefficient in Cervical Cancer: A Preliminasy Study on Histological Grade Evaluation. Journal of Magnetic Resonance Imaging, 49, 280-290. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, Y., Ye, Z., Sun, H., et al. (2015) Clinical Application of Diffu-sion-Weighted Magnetio Resonance Imaging in Utertne Cercal Cancer. International Journal of Gynecologic Cancer, 25, 1073-1078. [Google Scholar] [CrossRef] 

为你推荐